George D. Yancopoulos, MD, PhD, is co-founder, president and chief scientific officer of Regeneron Pharmaceuticals. He has led Regeneron alongside co-founder and CEO Len Schleifer, MD, PhD, since 1989 and served as a principal inventor and developer of Regeneron’s six FDA-approved drugs and foundational technologies, including the Trap technology VelociGene^® and VelocImmune^®. 

Dr. Yancopoulos has been driven by science his entire life. He began his education at the Bronx High School of Science, received his MD and PhD from Columbia University and went on to become the 11th most highly cited scientist in the world in the 1990s.  

In 2004, Dr. Yancopoulos was elected to be a member of the National Academy of Sciences.